Advertisement
Screener

BIOCERES CROP SOLUTIONS CORP. (BIOX) Profit Loss Attributable To Ordinary Equity Holders Of Parent Entity Including Dilutive Effects

BIOCERES CROP SOLUTIONS CORP. Profit Loss Attributable To Ordinary Equity Holders Of Parent Entity Including Dilutive Effects

BIOCERES CROP SOLUTIONS CORP. (BIOX) reported Profit Loss Attributable To Ordinary Equity Holders Of Parent Entity Including Dilutive Effects of -$183.04 million for the 3-month period ending 2025-12-31, per its 6-K filed 2026-03-13.

Financial Statements › Income Statement › Earnings Per Share

ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects · last filed 2026-03-13

  • BIOCERES CROP SOLUTIONS CORP. profit loss attributable to ordinary equity holders of parent entity including dilutive effects for the quarter ending 2025-12-31 was -$183.04M, a 127622.78% decline year-over-year.
  • BIOCERES CROP SOLUTIONS CORP. profit loss attributable to ordinary equity holders of parent entity including dilutive effects for the quarter ending 2025-09-30 was -$7.33M.
  • BIOCERES CROP SOLUTIONS CORP. profit loss attributable to ordinary equity holders of parent entity including dilutive effects for the quarter ending 2025-06-30 was -$47.89M.
  • BIOCERES CROP SOLUTIONS CORP. profit loss attributable to ordinary equity holders of parent entity including dilutive effects for the quarter ending 2025-03-31 was -$1.30M, a 114.09% decline year-over-year.
Period endProfit Loss Attributable To Ordinary Equity Holders Of Parent Entity Including Dilutive Effects 3 monthProfit Loss Attributable To Ordinary Equity Holders Of Parent Entity Including Dilutive Effects 6 monthProfit Loss Attributable To Ordinary Equity Holders Of Parent Entity Including Dilutive Effects 9 monthProfit Loss Attributable To Ordinary Equity Holders Of Parent Entity Including Dilutive Effects 12 monthProfit Loss Attributable To Ordinary Equity Holders Of Parent Entity Including Dilutive Effects 12 month as first filed
2025-12-31-$183.04M
6-K · filed 2026-03-13
-$190.37M
6-K · filed 2026-03-13
-$238.25M
derived: sum of 3 quarters · filed 2026-03-13
-$239.56M
derived: sum of 4 quarters · filed 2026-03-13
2025-09-30-$7.33M
6-K · filed 2025-11-26
-$55.21M
derived: sum of 2 quarters · filed 2025-11-26
-$56.52M
derived: sum of 3 quarters · filed 2025-11-26
-$56.37M
derived: sum of 4 quarters · filed 2026-03-13
2025-06-30-$47.89M
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
-$49.19M
derived: sum of 2 quarters · filed 2025-11-10
-$49.05M
derived: sum of 3 quarters · filed 2026-03-13
-$55.42M
20-F · filed 2025-11-10
2025-03-31-$1.30M
6-K · filed 2025-06-20
-$1.16M
derived: sum of 2 quarters · filed 2026-03-13
-$7.53M
6-K · filed 2025-06-20
-$8.03M
derived: sum of 4 quarters · filed 2026-03-13
2024-12-31$143.53K
6-K · filed 2026-03-13
-$6.23M
6-K · filed 2026-03-13
-$6.72M
derived: sum of 3 quarters · filed 2026-03-13
$2.53M
derived: sum of 4 quarters · filed 2026-03-13
2024-09-30-$6.37M
6-K · filed 2025-11-26
-$6.87M
derived: sum of 2 quarters · filed 2025-11-26
$2.39M
derived: sum of 3 quarters · filed 2025-11-26
$2.50M
derived: sum of 4 quarters · filed 2025-11-26
2024-06-30-$498.35K
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
$8.76M
derived: sum of 2 quarters · filed 2025-11-10
$8.87M
derived: sum of 3 quarters · filed 2025-11-10
$4.28M
20-F · filed 2025-11-10
$3.24M
20-F · filed 2024-10-30
2024-03-31$9.26M
6-K · filed 2025-06-20
$9.37M
derived: sum of 2 quarters · filed 2025-06-20
$4.77M
6-K · filed 2025-06-20
$3.07M
derived: sum of 4 quarters · filed 2025-11-10
2023-12-31$108.45K
6-K · filed 2025-02-28
-$4.48M
6-K · filed 2025-02-28
-$6.19M
derived: sum of 3 quarters · filed 2025-11-10
$21.96M
derived: sum of 4 quarters · filed 2025-11-10
2023-09-30-$4.59M
6-K · filed 2024-11-27
-$6.30M
derived: sum of 2 quarters · filed 2025-11-10
$21.85M
derived: sum of 3 quarters · filed 2025-11-10
$13.69M
derived: sum of 4 quarters · filed 2025-11-10
2023-06-30-$1.71M
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
$26.44M
derived: sum of 2 quarters · filed 2025-11-10
$18.28M
derived: sum of 3 quarters · filed 2025-11-10
$18.78M
20-F · filed 2025-11-10
2023-03-31$28.15M
6-K · filed 2024-05-29
$19.99M
derived: sum of 2 quarters · filed 2024-05-29
$20.49M
6-K · filed 2024-05-29
$15.47M
derived: sum of 4 quarters · filed 2024-10-30
2022-12-31-$8.16M
6-K · filed 2024-02-28
-$7.66M
6-K · filed 2024-02-28
-$12.67M
derived: sum of 3 quarters · filed 2024-10-30
-$19.16M
derived: sum of 4 quarters · filed 2024-10-30
2022-09-30$498.30K
6-K · filed 2023-11-29
-$4.52M
derived: sum of 2 quarters · filed 2024-10-30
-$11.00M
derived: sum of 3 quarters · filed 2024-10-30
-$7.58M
derived: sum of 4 quarters · filed 2024-10-30
2022-06-30-$5.01M
derived: 20-F 12 month − 6-K 9 month · filed 2024-10-30
-$11.50M
derived: sum of 2 quarters · filed 2024-10-30
-$8.07M
derived: sum of 3 quarters · filed 2024-10-30
-$7.20M
20-F · filed 2024-10-30
2022-03-31-$6.49M
6-K · filed 2023-05-24
-$3.06M
derived: sum of 2 quarters · filed 2023-05-24
-$2.19M
6-K · filed 2023-05-24
2021-12-31$3.43M
6-K · filed 2023-02-28
$4.30M
6-K · filed 2023-02-28
2021-06-30-$6.87M
20-F · filed 2023-11-14
2020-12-31$648.19K
6-K · filed 2022-02-25
-$6.32M
6-K · filed 2022-02-25
2020-06-30$3.36M
20-F · filed 2022-10-28
2019-12-31$4.26M
6-K · filed 2021-02-26
2019-06-30-$18.37M
20-F · filed 2021-10-29
2018-12-31$4.23M
6-K/A · filed 2020-03-17
2018-06-30-$11.04M
20-F · filed 2020-10-21